TGI-5
TGI5-T1-01
Phase 1 small_molecule active
Quick answer
TGI-5 for CRC (Colorectal Cancer) is a Phase 1 program (small_molecule) at TG THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TG THERAPEUTICS, INC.
- Indication
- CRC (Colorectal Cancer)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active